These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25222655)

  • 1. Impact of abdominal visceral adipose tissue on disease outcome in pediatric Crohn's disease.
    Uko V; Vortia E; Achkar JP; Karakas P; Fiocchi C; Worley S; Kay MH
    Inflamm Bowel Dis; 2014 Dec; 20(12):2286-91. PubMed ID: 25222655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
    Sehgal P; Su S; Zech J; Nobel Y; Luk L; Economou I; Shen B; Lewis JD; Freedberg DE
    Inflamm Bowel Dis; 2024 Apr; 30(4):594-601. PubMed ID: 37307420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
    Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
    Inflamm Bowel Dis; 2019 Feb; 25(3):592-600. PubMed ID: 30215805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
    Yarur AJ; Bruss A; Moosreiner A; Beniwal-Patel P; Nunez L; Berens B; Colombel JF; Targan SR; Fox C; Melmed GY; Abreu MT; Deepak P
    Gastroenterology; 2023 Oct; 165(4):963-975.e5. PubMed ID: 37499955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.
    Van Der Sloot KW; Joshi AD; Bellavance DR; Gilpin KK; Stewart KO; Lochhead P; Garber JJ; Giallourakis C; Yajnik V; Ananthakrishnan AN; Alizadeh BZ; Xavier RJ; Khalili H
    Inflamm Bowel Dis; 2017 Jan; 23(1):82-88. PubMed ID: 27893544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral Adipose Tissue in Patients with Crohn's Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome.
    Büning C; von Kraft C; Hermsdorf M; Gentz E; Wirth EK; Valentini L; Haas V
    Inflamm Bowel Dis; 2015 Nov; 21(11):2590-7. PubMed ID: 26222339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric visceral fat machine learning phenotype on CT for differential diagnosis of inflammatory bowel disease.
    Zhou Z; Xiong Z; Cheng R; Luo Q; Li Y; Xie Q; Xiao P; Hu D; Hu X; Shen Y; Li Z
    Eur Radiol; 2023 Mar; 33(3):1862-1872. PubMed ID: 36255487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
    Gu P; Chhabra A; Chittajallu P; Chang C; Mendez D; Gilman A; Fudman DI; Xi Y; Feagins LA
    Inflamm Bowel Dis; 2022 May; 28(5):657-666. PubMed ID: 34291800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
    Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
    Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiological biomarkers reflecting visceral fat distribution help distinguish inflammatory bowel disease subtypes: a multicenter cross-sectional study.
    Xiong Z; Wu P; Zhang Y; Chen J; Shen Y; Kamel I; Wu B; Zheng X; Li Z
    Insights Imaging; 2024 Mar; 15(1):70. PubMed ID: 38472526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma.
    Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Aoki T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Noda M; Itoh T; Mizokami M; Uemura N
    Int J Cancer; 2014 Nov; 135(10):2273-81. PubMed ID: 24692064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease.
    Simon TG; Van Der Sloot KWJ; Chin SB; Joshi AD; Lochhead P; Ananthakrishnan AN; Xavier R; Chung RT; Khalili H
    Inflamm Bowel Dis; 2018 Sep; 24(10):2247-2257. PubMed ID: 29788077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control Study.
    Spoendlin J; Karatas G; Furlano RI; Jick SS; Meier CR
    Inflamm Bowel Dis; 2016 Mar; 22(3):680-7. PubMed ID: 26717319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
    Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
    Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body Composition Predictors of Complicated Crohn's Disease.
    Barajas Ordonez F; Melekh B; Rodríguez-Feria P; Melekh O; Thormann M; Damm R; Omari J; Pech M; Surov A
    Dig Dis; 2023; 41(4):589-599. PubMed ID: 36720207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
    Lashner BA; Shaheen NJ; Hanauer SB; Kirschner BS
    Am J Gastroenterol; 1993 Mar; 88(3):356-9. PubMed ID: 8438840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.